Belvedere Trading’s Zimmer Biomet ZBH Stock Holding History

Belvedere Trading’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,914	Closed	-$431K	–	360
2014 Q4	$431K	Buy	+3,914	New	+$413K	﹤0.01%	254

Other funds holding ZBH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Belvedere Trading's ZBH Position: Q1 2015 in Review

Belvedere Trading sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 3,914 shares — an estimated $431K sold.

Belvedere Trading first reported a position in ZBH in Q4 2014 and held it in 1 quarter. The position peaked at $431K in Q4 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

Belvedere Trading reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
Belvedere Trading sold 3,914 Zimmer Biomet shares in Q1 2015, an estimated $431K.
Belvedere Trading first reported a position in Zimmer Biomet in Q4 2014 and held it in 1 quarter.
Belvedere Trading's Zimmer Biomet position peaked at $431K in Q4 2014.
762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.